IL85988A - 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them - Google Patents

1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them

Info

Publication number
IL85988A
IL85988A IL85988A IL8598888A IL85988A IL 85988 A IL85988 A IL 85988A IL 85988 A IL85988 A IL 85988A IL 8598888 A IL8598888 A IL 8598888A IL 85988 A IL85988 A IL 85988A
Authority
IL
Israel
Prior art keywords
phenyl
propanamines
naphthalenyloxy
preparation
pharmaceutical compositions
Prior art date
Application number
IL85988A
Other languages
English (en)
Other versions
IL85988A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL85988A0 publication Critical patent/IL85988A0/xx
Publication of IL85988A publication Critical patent/IL85988A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL85988A 1987-04-09 1988-04-06 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them IL85988A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3653487A 1987-04-09 1987-04-09

Publications (2)

Publication Number Publication Date
IL85988A0 IL85988A0 (en) 1988-09-30
IL85988A true IL85988A (en) 1992-08-18

Family

ID=21889125

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85988A IL85988A (en) 1987-04-09 1988-04-06 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
EP (1) EP0288188B1 (xx)
JP (1) JPH0637443B2 (xx)
KR (1) KR960007723B1 (xx)
CN (1) CN1020093C (xx)
AT (1) ATE68473T1 (xx)
AU (1) AU602971B2 (xx)
CA (1) CA1329937C (xx)
CY (1) CY1658A (xx)
DE (1) DE3865504D1 (xx)
DK (1) DK170637B1 (xx)
EG (1) EG18584A (xx)
ES (1) ES2045109T3 (xx)
GR (1) GR3003267T3 (xx)
HK (1) HK63992A (xx)
HU (1) HU204767B (xx)
IL (1) IL85988A (xx)
MX (1) MX11031A (xx)
NZ (1) NZ224161A (xx)
PH (1) PH27141A (xx)
PT (1) PT87163B (xx)
SG (1) SG67092G (xx)
SU (1) SU1568886A3 (xx)
ZA (1) ZA882418B (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK258389D0 (da) * 1989-05-26 1989-05-26 Ferrosan As Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
CA2061665C (en) * 1991-02-25 2002-04-16 Mark Mortensen Foreman Treatment of lower urinary tract disorders
WO1993013049A1 (fr) * 1991-12-20 1993-07-08 Karin Elisabeth Peuschel Emploi de l'effet immunoactivant de 3-naphthyloxy-2-hydroxy-propylamines, interessant specialement pour l'immunite cellulaire, par exemple contre infections virales
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
US5948820A (en) * 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
KR100358922B1 (ko) * 1994-08-22 2003-01-24 미쯔비시 웰 파마 가부시키가이샤 벤젠화합물및그의의약으로서의용도
DE19956786A1 (de) * 1999-11-25 2001-05-31 Basf Ag Verfahren zur Herstellung optisch aktiver Amine
CN100402488C (zh) * 2006-03-15 2008-07-16 上海玛耀化学技术有限公司 一种达泊西汀的合成方法
WO2008035358A2 (en) * 2006-06-05 2008-03-27 Cadila Healthcare Limited Process for preparing dapoxetine
CN101367739B (zh) * 2008-09-24 2013-02-13 台州职业技术学院 N,n-二甲基-1-苯基-3-(1-萘氧基)丙胺制备工艺
DE102009015702A1 (de) 2009-03-31 2010-10-07 Ratiopharm Gmbh Tabletten enthaltend Dapoxetin und Trockenverarbeitungsverfahren zu deren Herstellung
WO2011058572A2 (en) 2009-11-13 2011-05-19 Symed Labs Limited Solid dapoxetine
DE102009058321A1 (de) 2009-12-15 2011-06-16 Ratiopharm Gmbh Schmelztablette, enthaltend Dapoxetin
WO2011161690A1 (en) * 2010-06-23 2011-12-29 Symed Labs Limited Processes for the preparation of (+)-n,n-dimethyl-2-[1-(naphthalenyloxy) ethyl] benzene methanamine and intermediates thereof
CN102229538B (zh) * 2011-05-11 2013-11-13 中南大学 一种达泊西汀的合成方法
CN102850318A (zh) * 2011-07-01 2013-01-02 中国人民解放军军事医学科学院毒物药物研究所 新的选择性5-羟色胺重摄取抑制剂及其医药用途
CN103130660B (zh) * 2011-11-25 2014-09-17 厦门福满药业有限公司 一类达泊西汀的酸式盐及其晶体,以及晶体的制备方法
WO2013180675A1 (en) 2012-05-28 2013-12-05 Mahmut Bilgic Tablet formulation comprising dapoxetine
CN102746170A (zh) * 2012-07-28 2012-10-24 湖南尔文生物科技有限公司 一种达泊西汀的制备方法
TR201309037A2 (tr) 2012-08-17 2014-03-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Dapoksetin ve bir pde5 inhibitörü içeren yeni efervesan saşe formülasyonları.
WO2014027979A2 (en) 2012-08-17 2014-02-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tablet formulations comprising tadalafil and dapoxetine
WO2014027981A2 (en) 2012-08-17 2014-02-20 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Effervescent tablet formulations of dapoxetine and a pde5 inhibitor
US20150216798A1 (en) 2012-08-17 2015-08-06 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Novel orally administered pharmaceutical formulations
US20150231092A1 (en) 2012-08-17 2015-08-20 Sanovell IIac Sanayi Ve Ticaret Anonim Sirketi Novel effervescent sachet formulations of dapoxetine and a pde5 inhibitor
US20150202168A1 (en) 2012-08-17 2015-07-23 Sanovel llac Sanayi Ve Ticaret Anonim Sirketi Oral film formulations comprising dapoxetine and tadalafil
CN102942496B (zh) * 2012-11-28 2014-06-11 扬州工业职业技术学院 (s)-n,n-二甲基-3-(萘酚-1-氧基)-1-苯基丙基-1-胺的制备方法
EP2749553A1 (en) 2012-12-31 2014-07-02 Deva Holding Anonim Sirketi Process for preparation of enantiomerically pure S-(+)-N, N-dimethyl-a-[2-(naphthalenyloxy)ethyl] benzenemethanamine
CN106748825A (zh) * 2016-11-29 2017-05-31 聊城大学 一种达泊西汀的合成、拆分纯化和成盐方法
CN108853072A (zh) * 2018-08-03 2018-11-23 安徽省金楠医疗科技有限公司 一种盐酸达泊西汀片及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4018895A (en) * 1974-01-10 1977-04-19 Eli Lilly And Company Aryloxyphenylpropylamines in treating depression
US4207343A (en) * 1978-06-22 1980-06-10 Eli Lilly And Company 1-Phenyl-3-(substituted phenoxy)propylamines
NZ213651A (en) * 1984-10-11 1989-07-27 Hoffmann La Roche Tetrahydronapthalene derivatives and medicaments

Also Published As

Publication number Publication date
PH27141A (en) 1993-04-02
GR3003267T3 (en) 1993-02-17
HK63992A (en) 1992-08-28
JPS63258837A (ja) 1988-10-26
DK170637B1 (da) 1995-11-20
EG18584A (en) 1994-07-30
DE3865504D1 (de) 1991-11-21
ATE68473T1 (de) 1991-11-15
CY1658A (en) 1993-05-14
PT87163A (pt) 1988-05-01
SU1568886A3 (ru) 1990-05-30
HU204767B (en) 1992-02-28
HUT50316A (en) 1990-01-29
JPH0637443B2 (ja) 1994-05-18
DK188288A (da) 1989-01-12
CN88102018A (zh) 1988-10-26
ES2045109T3 (es) 1994-01-16
CN1020093C (zh) 1993-03-17
CA1329937C (en) 1994-05-31
NZ224161A (en) 1990-04-26
DK188288D0 (da) 1988-04-07
ZA882418B (en) 1989-12-27
AU602971B2 (en) 1990-11-01
EP0288188B1 (en) 1991-10-16
AU1433588A (en) 1988-10-13
PT87163B (pt) 1992-07-31
EP0288188A1 (en) 1988-10-26
MX11031A (es) 1993-11-01
KR880012526A (ko) 1988-11-28
KR960007723B1 (ko) 1996-06-11
SG67092G (en) 1992-09-04
IL85988A0 (en) 1988-09-30

Similar Documents

Publication Publication Date Title
IL85988A (en) 1-phenyl-3-naphthalenyloxy-propanamines,process for their preparation and pharmaceutical compositions containing them
JO1351B1 (en) Chemical compounds
HUT43051A (en) Process for preparing pyridine-carboxylic acid derivatives and pharmaceutical compositions containing thereof as active ingredients
HUT40101A (en) Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
HUT45230A (en) Process for producing new phenoxy-acetic acid derivatives and pharmaceuticals comprising such compounds
ES8606330A1 (es) Procedimiento para preparar derivados de acidos quinolincar-boxilicos
DE3363550D1 (en) New nitro aliphatic compounds, process for preparation thereof and use thereof
PH24176A (en) New bicyclic compounds,process for preparation thereof and pharmaceutical composition comprising the same
ES8700242A1 (es) Un procedimiento para preparar un derivado de dihidropirida-zinona
HUT50352A (en) Process for producing new antiviral prine derivatives and pharmaceutical compositions comprising same
DE3661311D1 (en) Novel guanidinomethylcyclohexancarboxylic acid compounds, processes for preparing them, and pharmaceutical compositions containing them
IE781467L (en) 4"-ureido-oleandomycin derivatives
IL87107A0 (en) Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them
ES8502094A1 (es) Un procedimiento para la preparacion de derivados de tetrahidroisoquinolina.
ES8300709A1 (es) Un metodo para la preparacion de derivados de pirazolidinona
ATE97902T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
ZA872925B (en) Heterocyclic compounds

Legal Events

Date Code Title Description
RH Patent void